December 13, 2023
Merdury BioPharmaceutical Inc And Shiner Pharm Corp Sign Technology Platform Licensing Agreement
Merdury BioPharmaceutical's New Drug Development Technology Platform Stackdose™ Enters UBI Pharma's PIC/S GMP Facility
Merdury BioPharmaceutical's Sildenafil Development Results Published in International Journal Life
January 13, 2026
Merdury Biopharmaceutical Corporation’s StackDose® 3D Printing Platform To Enter Bora Pharmaceuticals’ Zhongli PIC/S GMP Facility
July 28, 2024
Merdury signs MOU with Health2Sync to conduct trial of Merdury’s StackDose technology intended for usage in GLP-1 (semaglutide) medication
